The Current Landscape of Antibody-based Therapies in Solid Malignancies

Over the past three decades, monoclonal antibodies (mAbs) have revolutionized the landscape of cancer therapy. Still, this benefit remains restricted to a small proportion of patients due to moderate response rates and resistance emergence. The field has started to embrace better mAb-based formats w...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Theranostics
Glavni autori: Shah, Ashu, Rauth, Sanchita, Aithal, Abhijit, Kaur, Sukhwinder, Ganguly, Koelina, Orzechowski, Catherine, Varshney, Grish C, Jain, Maneesh, Batra, Surinder K
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2021
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738893/
https://ncbi.nlm.nih.gov/pubmed/33391547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.52614
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items